News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Somnomed.
RELATED STOCKHEAD STORIES
News
ASX Quarterlies: Junior techs and biotechs still thriving despite difficult conditions
News
ASX Quarterlies: Biotechs deliver strong performances for shareholders
Health & Biotech
ASX Health Stocks: Cochlear’s profit down 28pc in first half, as Estia’s aged care struggles with Omicron outbreak
Health & Biotech
ASX Health Stocks: Resapp gains on India COVID-19 trial, Atomo to supply HIV self-test in Australia
Director Trades
Directors’ Trades: As Nuix recovers from last month’s lows, one director made a $501,180 buy
Health & Biotech
ScoPo’s powerplays: It’s been ‘like a waterfall of information’ hitting us daily
Health & Biotech
SomnoMed taps tech for new board hires, posts full-year profit
Experts
Scopo’s powerplays: Investors love a result, until they don’t
News
What ASX investors should look for in a COVID-19 earnings season
Food & Agriculture
Economic recovery post-COVID, the five sectors that will lead the charge
Health & Biotech
These are the life sciences small caps almost unscathed by COVID-19
Experts
Scopo’s powerplays: It just won’t go down!
Health & Biotech
The health stocks still taking a hit from COVID-19
Health & Biotech
Check up: Diarrhoea and the FDA are lifting share prices
Health & Biotech
Check up: Sometimes no news is good news
Experts
Scopo’s health powerplays: You’re all going to the pot, literally
Health & Biotech
